These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34415738)

  • 1. Chemical Modulators of Mucosal Associated Invariant T Cells.
    Mak JYW; Liu L; Fairlie DP
    Acc Chem Res; 2021 Sep; 54(17):3462-3475. PubMed ID: 34415738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
    Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
    Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Immunomodulators Developed from an Unstable Bacterial Metabolite of Vitamin B2 Biosynthesis.
    Mak JYW; Rivero RJD; Hoang HN; Lim XY; Deng J; McWilliam HEG; Villadangos JA; McCluskey J; Corbett AJ; Fairlie DP
    Angew Chem Int Ed Engl; 2024 Jul; 63(31):e202400632. PubMed ID: 38679861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview on the identification of MAIT cell antigens.
    Kjer-Nielsen L; Corbett AJ; Chen Z; Liu L; Mak JY; Godfrey DI; Rossjohn J; Fairlie DP; McCluskey J; Eckle SB
    Immunol Cell Biol; 2018 Jul; 96(6):573-587. PubMed ID: 29656544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
    Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
    J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
    Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
    Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
    Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
    Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modelling of new potent clickable analogues of 5-OP-RU for their use as chemical probes for the study of MAIT cell biology.
    Yvorra T; Steinmetz A; Retailleau P; Lantz O; Schmidt F
    Eur J Med Chem; 2021 Feb; 211():113066. PubMed ID: 33341648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical insights into the search for MAIT cells activators.
    Veerapen N; Hobrath J; Besra AK; Besra GS
    Mol Immunol; 2021 Jan; 129():114-120. PubMed ID: 33293098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
    Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
    Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer Modelling and Synthesis of Deoxy and Monohydroxy Analogues of a Ribitylaminouracil Bacterial Metabolite that Potently Activates Human T Cells.
    Ler GJM; Xu W; Mak JYW; Liu L; Bernhardt PV; Fairlie DP
    Chemistry; 2019 Dec; 25(68):15594-15608. PubMed ID: 31529537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
    Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
    J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells.
    Mak JY; Xu W; Reid RC; Corbett AJ; Meehan BS; Wang H; Chen Z; Rossjohn J; McCluskey J; Liu L; Fairlie DP
    Nat Commun; 2017 Mar; 8():14599. PubMed ID: 28272391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
    Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
    J Biol Chem; 2024 Jun; 300(6):107338. PubMed ID: 38705391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens.
    Rashu R; Ninkov M; Wardell CM; Benoit JM; Wang NI; Meilleur CE; D'Agostino MR; Zhang A; Feng E; Saeedian N; Bell GI; Vahedi F; Hess DA; Barr SD; Troyer RM; Kang CY; Ashkar AA; Miller MS; Haeryfar SMM
    PLoS Pathog; 2023 Jun; 19(6):e1011485. PubMed ID: 37384813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic 5-amino-6-D-ribitylaminouracil paired with inflammatory stimuli facilitates MAIT cell expansion
    Nelson AG; Wang H; Dewar PM; Eddy EM; Li S; Lim XY; Patton T; Zhou Y; Pediongco TJ; Meehan LJ; Meehan BS; Mak JYW; Fairlie DP; Stent AW; Kjer-Nielsen L; McCluskey J; Eckle SBG; Corbett AJ; Souter MNT; Chen Z
    Front Immunol; 2023; 14():1109759. PubMed ID: 37720229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
    Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
    Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis underpinning the potency and specificity of MAIT cell antigens.
    Awad W; Ler GJM; Xu W; Keller AN; Mak JYW; Lim XY; Liu L; Eckle SBG; Le Nours J; McCluskey J; Corbett AJ; Fairlie DP; Rossjohn J
    Nat Immunol; 2020 Apr; 21(4):400-411. PubMed ID: 32123373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.